Labormed
13 articole · RSS
Zentiva Completes Acquisition of Alvogen's CEE Operations Including Romanian Labormed
Zentiva Group, owned by Advent International, announced Tuesday it has completed the acquisition of Alvogen's Central and Eastern European (CEE) business.
Zentiva Group Buys Alvogen’s Operations In CEE, Including Labormed Plant In Romania
Zentiva Group, also present on the Romanian market, has announced the acquisition of the operations in Central and Eastern Europe of pharmaceuticals company Alvogen, for an undisclosed amoun...
Labormed Posts 61% Higher Sales, 84% Lower Loss In 2013, 1st Year Under Alvogen’s Control
Sales of Romanian generic drug producer Labormed Pharma surged nearly 61% to 141.8 million lei (EUR32 million) and its loss narrowed by 84% to RON18 million in 2013, the first year under the...
Advent Sold Labormed For $33M, 20% Of Acquisition Price
Investment fund Advent sold Romanian generic drug producer Labormed last year to U.S. pharmaceutical company Alvogen for $33 million (EUR24 million), less than 20% of the acquisition price p...
PlantExtrakt Reintroduces In Its Portfolio 12 Brands Sold To Labormed In 2009
Cluj-based company Laboratoarele PlantExtrakt, which produces homeopathic medicines and herbal remedies, has reintroduced in its portfolio the 12 brands it had sold to Romanian drug producer...
Stephen Stead Returns To Pharmaceutical Market As Ranbaxy Regional Director
British-born Stephen Stead, who in August 2012 stepped down as CEO of Labormed, has returned to the pharmaceutical industry in a regional position within Ranbaxy and is based in Romania. He...
Advent’s Portfolio In Romania Includes Only Two Companies After Two More Exits
Investment fund Advent Internaținal sold two of its Romanian businesses over the past year: medical drug producer Labormed in August 2012 and paint maker Deutek this month.
New Owner Of Labormed Wants Less Reliance On Romanian Market
The priority of the new owner of pharmaceutical producer Labormed, Alvogen, is to make the company less reliant on the Romanian market, says Laurentiu Scheusan, Alvogen’s executive vice pres...
U.S. Alvogen Acquires Generic Drug Maker Labormed
U.S. pharmaceutical company Alvogen on Thursday said it acquired Romanian generic drug producer Labormed in December 2012 from private equity firm Advent International.